BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32537923)

  • 1. Left maxillary sinus tumour-induced hypophosphataemic osteomalacia and combined with thyroid papillary carcinoma: a case report and literature review.
    Li B; Dong Y; Liu D; Yao Q; Guo S; Xin H; Wang H; Liu L; Zhang Y
    Intern Med J; 2020 Jun; 50(6):755-761. PubMed ID: 32537923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-induced osteomalacia: a literature review and a case report.
    Dadoniene J; Miglinas M; Miltiniene D; Vajauskas D; Seinin D; Butenas P; Kacergius T
    World J Surg Oncol; 2016 Jan; 14(1):4. PubMed ID: 26744291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal phosphaturic neoplasm in the maxillary sinus: a case report.
    Pedrazzoli M; Colletti G; Ferrari M; Rossetti G; Moneghini L; Autelitano L
    Int J Oral Maxillofac Surg; 2010 Oct; 39(10):1027-32. PubMed ID: 20483563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal phosphaturic tumour: early detection of recurrence.
    Allevi F; Rabbiosi D; Mandalà M; Colletti G
    BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24827649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenging case of tumour-induced osteomalacia.
    Kumar P; Jadhav DV; Ravat SH; Jain N
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35589273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-induced osteomalacia (TIO).
    Molendowska A; Jakubowska J; Jędrzejuk D; Szymczak J
    Endokrynol Pol; 2022; 73(5):903-904. PubMed ID: 36621920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic prostate cancer presenting as tumour-induced osteomalacia.
    Layman AAK; Joshi S; Shah S
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31315844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET/CT localisation of a scapular haemangiopericytoma with tumour-induced osteomalacia.
    Khadgawat R; Singh Y; Kansara S; Tandon N; Bal C; Seith A; Kotwal P
    Singapore Med J; 2009 Feb; 50(2):e55-7. PubMed ID: 19296011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
    Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
    G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-induced osteomalacia.
    Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
    Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-induced Osteomalacia in a 3-Year-Old With Unresectable Central Giant Cell Lesions.
    Crossen SS; Zambrano E; Newman B; Bernstein JA; Messner AH; Bachrach LK; Twist CJ
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):e21-e24. PubMed ID: 27820122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23.
    Nasu T; Kurisu S; Matsuno S; Tatsumi K; Kakimoto T; Kobayashi M; Nakano Y; Wakasaki H; Furuta H; Nishi M; Sasaki H; Suzuki H; Ito N; Fukumoto S; Nanjo K
    Intern Med; 2008; 47(10):957-61. PubMed ID: 18480582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic osteomalacia: strange tumours in strange places.
    Weiss D; Bar RS; Weidner N; Wener M; Lee F
    Postgrad Med J; 1985 Apr; 61(714):349-55. PubMed ID: 4022870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypophosphataemic osteomalacia due to de Toni-Debre-Fanconi syndrome in a 19-year old girl.
    Tsilchorozidou T; Yovos JG
    Hormones (Athens); 2005; 4(3):171-6. PubMed ID: 16613828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-induced osteomalacia: a rare cause of chronic pain and weakness.
    Nasr JT; Tohme J; Collins MT; Drake MT; Hartley IR; Sfeir J; Dockery K; Taskin M
    Pract Neurol; 2022 Dec; 22(6):528-531. PubMed ID: 35896375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A literature review to understand the burden of disease in people living with tumour-induced osteomalacia.
    Minisola S; Barlassina A; Vincent SA; Wood S; Williams A
    Osteoporos Int; 2022 Sep; 33(9):1845-1857. PubMed ID: 35643939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learnt from delayed diagnosis of FGF-23-producing tumour-induced osteomalacia and post-operative hungry bone syndrome.
    Kumar S; Diamond T
    Bone Rep; 2020 Jun; 12():100276. PubMed ID: 32455150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic osteomalacia -- hypophosphataemic spectrum from "benignancy" to "malignancy".
    Chiam P; Tan HC; Bee YM; Chandran M
    Bone; 2013 Mar; 53(1):182-7. PubMed ID: 23220596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypophosphatemic oncogenic osteomalacia].
    Mátyus J; Szebenyi B; Rédl P; Mikita J; Gáspár L; Haris A; Radó J; Kakuk G
    Orv Hetil; 2000 Dec; 141(51):2785-8. PubMed ID: 11196239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced Osteomalacia in a Boy with Maxillary Ossifying Fibroma.
    Thi HN; Manh CP; Tuan LT; Le Thi LA; Thanh NN; Vilaiyuk S
    J Clin Res Pediatr Endocrinol; 2023 Nov; 15(4):421-425. PubMed ID: 35135186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.